drugset / Trial / NCT03309202
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment
Non-randomizedParallel-groupOpen-labelBasic science
Summary
Hepatic impairment PK study
Timeline
- Start
- 2017-12-19
- Primary completion
- 2018-06-26
- Completion
- 2018-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clesacostat | Small molecule | 25 mg | Oral |